Literature DB >> 4430721

Effects of steroid hormones on human polymorphonuclear leukocyte lysosomes.

R H Persellin, L C Ku.   

Abstract

Lysosomal membrane stabilization has been proposed as a mechanism for the anti-inflammatory action of corticosteroid hormones. This hypothesis was based on studies with liver organelles. We studied the action of steroids on intact lysosomes isolated from human peripheral blood polymorphonuclear (PMN) leukocytes. Both androstenedione and progesterone, 10(-3)-10(-5) M, caused leakage of acid hydrolase markers from these organelles, thus resembling their effects on liver lysosomes. But none of the anti-inflammatory steroids tested protected organelle membranes from either detergent lysis (Triton X-100) or heat incubation (37 degrees C, 90 min). Hydrocortisone (HC), HC sodium succinate, HC acetate, HC hemisuccinate, prednisone, and dexamethasone were without detectable stabilizing activity at concentrations of 10(-3)-5 x 10(-8) M. Release of the lysosomal marker, beta-glucuronidase, was not retarded by any of the compounds studied. In addition, PMN leukocyte lysosomes isolated from human volunteers receiving prednisolone were not more stable than control organelles, nor did serum from steroid-treated humans protect intact lysosomes from detergent lysis. Variations in cholesterol and phospholipid contents of liver and PMN leukocyte lysosome membranes could possibly account for the different reactivity to corticosteroids observed. We believe that the anti-inflammatory activity of adrenal corticosteroids can best be explained by their inhibitory effects on cellular metabolism rather than by their direct interaction with lysosomal membranes.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4430721      PMCID: PMC301632          DOI: 10.1172/JCI107832

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Suppression of enzyme release from isolated rat liver lysosomes by non-steroidal anti-inflammatory drugs.

Authors:  K Tanaka; Y Iizuka
Journal:  Biochem Pharmacol       Date:  1968-10       Impact factor: 5.858

2.  Isolation of human PMN leukocytes and granules: observations on early blood diluion and on heparin.

Authors:  W B Chodirker; G N Bock; J H Vaughan
Journal:  J Lab Clin Med       Date:  1968-01

Review 3.  The role of lysosomes in inflammation and disease.

Authors:  G Weissmann
Journal:  Annu Rev Med       Date:  1967       Impact factor: 13.739

4.  Effect of pregnancy sera on isolated lysosomes.

Authors:  K H Hempel; L A Fernandez; R H Persellin
Journal:  Nature       Date:  1970-03-07       Impact factor: 49.962

5.  Interaction of lysosomes and anti-infalmmatory drugs.

Authors:  J H Brown; N L Schwartz
Journal:  Proc Soc Exp Biol Med       Date:  1969-06

6.  Glucocorticoid action on rat thymus cells. Interrelationships between carbohydrate, protein, and adenine nucleotide metabolism and cortisol effects on these functions in vitro.

Authors:  D A Young
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

7.  Lysosome stabilization by leukocyte granule membrane antiserum.

Authors:  R H Persellin
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

8.  Plasma kinins and cortisol: a possible explanation of the anti-inflammatory action of cortisol.

Authors:  M J Cline; K L Melmon
Journal:  Science       Date:  1966-09-02       Impact factor: 47.728

9.  Composition and properties of a cell-membrane fraction from the polymorphonuclear leucocyte.

Authors:  A M Woodin; A A Wieneke
Journal:  Biochem J       Date:  1966-05       Impact factor: 3.857

10.  Resolution of granules from rabbit heterophil leukocytes into distinct populations by zonal sedimentation.

Authors:  M Baggiolini; J G Hirsch; C De Duve
Journal:  J Cell Biol       Date:  1969-02       Impact factor: 10.539

View more
  15 in total

1.  Influence of corticosteroids on human polymorphonuclear leukocyte function in vitro : Reduction of lysosomal enzyme release and superoxide production.

Authors:  I M Goldstein; D Roos; G Weissmann; H B Kaplan
Journal:  Inflammation       Date:  1976-06       Impact factor: 4.092

2.  Protective effect of methylprednisolone on ischaemic myocardium assessed by ventricular function.

Authors:  B L Krause; M A Hassan; A B McMilan; A H Brown
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

Review 3.  Intra-articular steroid injection. A risk-benefit assessment.

Authors:  B Grillet; J Dequeker
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

4.  Influence of hydrocortisone on the modulation of the inflammatory response.

Authors:  G Tolone; L Bonasera; C Tolone
Journal:  Br J Exp Pathol       Date:  1978-08

5.  Female sex hormones and lysosomal stability in gingival polymorphonuclear leucocytes.

Authors:  F Jaccard; G Cimasoni
Journal:  Experientia       Date:  1979-10-15

Review 6.  Stress-linked cortisol concentrations in hair: what we know and what we need to know.

Authors:  Christopher F Sharpley; James R McFarlane; Andrzej Slominski
Journal:  Rev Neurosci       Date:  2011-12-08       Impact factor: 4.353

7.  The effects of prednisolone in leucocyte function in man. A double blind controlled study.

Authors:  J R Clarke; R F Gagnon; F M Gotch; M R Heyworth; I C Maclennan; S C Truelove; C A Waller
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

8.  Effect of estradiol and progesterone on lymphocyte and neutrophil functions in steers.

Authors:  J A Roth; M L Kaeberle; W H Hsu
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  In vitro effect of hydrocortisone on the attachment and ingestion phases of immunoglobulin G- and complement component 3b-mediated phagocytosis by human neutrophils.

Authors:  J Forslid; J Hed
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

10.  Cellular immunity to toxoplasma and besnoitia in hamsters: specificity and the effects of cortisol.

Authors:  R E Lindberg; J K Frenkel
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.